PE-backed NutraQ sold to trade in NOK 3.1bn deal
NutraQ, backed by private equity firm Impilo and Sana Pharma Holding, has been sold to listed company Orkla for NOK 3.1bn (тЌ303.5m).Т
The exit comes three years after Impilo, a Nordic investment company focused on investments in the healthcare sector, acquired a 51% stake in the company in December 2017.
Based on the company's 2020 EBITDA of NOK 188m, the deal achieved an EBITDA multiple of 16.5x.
The acquisition will help Orkla – a supplier of branded consumer goods to grocery stores and bakers – to "bring new competence, more sales channels and a larger international scope of growth", according to the company.
The deal is subject to regulatory approval.
Company
Founded in 2002 and based in Oslo, NutraQ is a supplier of subscription-based health and beauty products in the Nordic region.
It owns health and beauty brands VitaePro and Oslo Skin Lab, men's health brands Maxulin and Provexin, and vitamin supplement brand Vesterålens Naturprodukter. The company has 150 employees and reported a turnover of NOK 862m in 2020 and EBITDA of NOK 188m.
People
Orkla – Jaan Ivar Semlitsch (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









